1,475 reports of this reaction
10.0% of all ELACESTRANT reports
#1 most reported adverse reaction
NAUSEA is the #1 most commonly reported adverse reaction for ELACESTRANT, manufactured by Stemline Therapeutics, Inc.. There are 1,475 FDA adverse event reports linking ELACESTRANT to NAUSEA. This represents approximately 10.0% of all 14,750 adverse event reports for this drug.
Patients taking ELACESTRANT who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among ELACESTRANT users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for ELACESTRANT:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 1,475 FDA reports for ELACESTRANT. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 10.0% of all adverse event reports for ELACESTRANT, making it one of the most commonly reported side effect.
If you experience nausea while taking ELACESTRANT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.